These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


244 related items for PubMed ID: 8853905

  • 1. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM, Huang Y, Fang G, Bhalla K.
    Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 3. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM, Liu L, Bhalla K.
    Cancer Res; 1997 Mar 15; 57(6):1109-15. PubMed ID: 9067280
    [Abstract] [Full Text] [Related]

  • 4. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
    Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G, Bhalla K.
    Cancer Res; 1997 Aug 01; 57(15):3115-20. PubMed ID: 9242435
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.
    Oncol Res; 1998 Aug 01; 10(6):313-24. PubMed ID: 9848102
    [Abstract] [Full Text] [Related]

  • 7. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.
    Kangas A, Nicholson DW, Hölttä E.
    Oncogene; 1998 Jan 22; 16(3):387-98. PubMed ID: 9467964
    [Abstract] [Full Text] [Related]

  • 8. Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
    Ponnathpur V, Ibrado AM, Reed JC, Ray S, Huang Y, Self S, Bullock G, Nawabi A, Bhalla K.
    Clin Cancer Res; 1995 Nov 22; 1(11):1399-406. PubMed ID: 9815937
    [Abstract] [Full Text] [Related]

  • 9. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.
    Schrantz N, Blanchard DA, Mitenne F, Auffredou MT, Vazquez A, Leca G.
    Cell Death Differ; 1999 May 22; 6(5):445-53. PubMed ID: 10381635
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.
    Saltzman A, Munro R, Searfoss G, Franks C, Jaye M, Ivashchenko Y.
    Exp Cell Res; 1998 Jul 10; 242(1):244-54. PubMed ID: 9665822
    [Abstract] [Full Text] [Related]

  • 11. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY, Stein CA.
    Clin Cancer Res; 1997 Nov 10; 3(11):2039-46. PubMed ID: 9815595
    [Abstract] [Full Text] [Related]

  • 12. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 10; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 13. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.
    An S, Park IC, Rhee CH, Hong SI, Knox K.
    Int J Oncol; 2003 Aug 10; 23(2):257-68. PubMed ID: 12851674
    [Abstract] [Full Text] [Related]

  • 14. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL, Dong YB, Elliott MJ, Liu TJ, McMasters KM.
    Clin Cancer Res; 2000 Apr 10; 6(4):1579-89. PubMed ID: 10778992
    [Abstract] [Full Text] [Related]

  • 15. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R.
    Biochem Cell Biol; 1997 Apr 10; 75(4):301-14. PubMed ID: 9493953
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels.
    Tudor G, Aguilera A, Halverson DO, Laing ND, Sausville EA.
    Cell Death Differ; 2000 Jun 10; 7(6):574-86. PubMed ID: 10822281
    [Abstract] [Full Text] [Related]

  • 17. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death.
    Kagawa S, Gu J, Honda T, McDonnell TJ, Swisher SG, Roth JA, Fang B.
    Clin Cancer Res; 2001 May 10; 7(5):1474-80. PubMed ID: 11350920
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
    Perkins C, Kim CN, Fang G, Bhalla KN.
    Cancer Res; 1998 Oct 15; 58(20):4561-6. PubMed ID: 9788601
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases.
    Kimura C, Zhao QL, Kondo T, Amatsu M, Fujiwara Y.
    Exp Cell Res; 1998 Mar 15; 239(2):411-22. PubMed ID: 9521859
    [Abstract] [Full Text] [Related]

  • 20. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
    Yang JS, Hour MJ, Kuo SC, Huang LJ, Lee MR.
    Anticancer Res; 2004 Mar 15; 24(3a):1769-78. PubMed ID: 15274354
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.